Azzedine Allouache

Azzedine Allouache is an experienced IT professional currently working at Sanofi, a global pharmaceutical company. With over 25 years of experience in the IT industry, he has established himself as a leader in ERP (Enterprise Resource Planning) systems and technical architecture.1

Professional Experience

Azzedine's current role at Sanofi is Head of ERP Platforms and Systems.45 He is also involved in the GLOBAL ERP (SHIFT) project as the Logical Design, Technical Architecture, and Integration Lead. This position likely involves overseeing the design and implementation of Sanofi's global ERP systems, ensuring they meet the company's technical and operational needs.

Areas of Expertise

Throughout his career, Azzedine has developed expertise in several areas:

• SAP Systems: He has significant experience with SAP implementations and innovations, including SAP S/4 HANA, SAP Build, SAP Business Technology Platform (BTP), and Cloud Application Programming (CAP).3
• Treasury Operations: Azzedine has been involved in SAP Treasury projects and has knowledge of global treasury operations.27
• Enterprise Architecture: He has shown interest in enterprise architecture management and its implementation in organizations.6

Education and Background

Azzedine Allouache holds a Master of Sciences degree and has studied at Cergy and Orsay universities.1 His career spans over two decades, with five years spent in consulting on various projects before joining the pharmaceutical industry, where he has worked for more than 15 years.

Current Focus

As of 2024, Azzedine is actively involved in Sanofi's digital transformation efforts, particularly in the areas of ERP systems and innovative technologies. He has been sharing opportunities for technical profiles interested in SAP S/4 innovation extensions, indicating his role in driving technological advancements within the company.3

Azzedine Allouache's LinkedIn profile (username: azzedineallouache) serves as a platform for him to share insights, job opportunities, and updates related to his work in the pharmaceutical and IT sectors.